|
 |
|
| Antimicrobial treatment in the
21st century:
Current challenges and future strategies
July 16-18, 2003
COEX CENTER, Seoul, KOREA
|
 |
|
|
Current
Challenges of Antimicrobial Treatment
:
Lessons from the 20th Century |
|
|
Global
Overview of Antimicrobial Resistance : Historical
Perspectives
Jae-Hoon
Song (Samsung
Medical Center, Sungkyunkwan Univ., Korea) |
Bacterial
Resistance : The Fight We Cannot Win
Jean-Claude
Pechere (Univ.
of Geneva, Switzerland) |
Dynamics
of the Evolution of Antimicrobial Resistance
Barbara
E. Murray (Univ.
of Texas, USA) |
New
Therapeutic Options from Current Antimicrobial
Armamentarium
Walter
R. Wilson (Mayo
Clinic, USA) |
The
Terrible Impact of AIDS on Africa : The
Case for Prevention and Treatment Now!
Merle
Sande (Univ.
of Utah, USA) |
HIV
Dynamics and Challenges for Antiretroviral
Therapy
Zelalem
Temesgen (Mayo
Clinic, USA) |
Severe
Acute Respiratory Syndrome (SARS) : New
Plague in the 21st Century
Joseph
Sung (P.R.
China) |
|
|
|
Pneumococcal
Resistance
In Conjunction with Infectious Diseases
Society of the Republic of China |
|
|
Pneumococcal
Resistance to Beta-Lactams and Macrolides
Jae-Hoon
Song (Samsung
Medical Center, Sungkyunkwan Univ., Korea) |
Pneumococcal
Resistance to Fluoroquinolones
Donald
E. Low (Mount
Sinai Hospital, Canada) |
Clinical
Implications : Pneumonia and Meningitis
Keith
P. Klugman (Emory
Univ., USA) |
Clinical
Implications : Otitis Media
Ron
Dagan (Soroka
Univ. Medical Center, Israel) |
Resistance
in Gram-Negative Bacilli |
|
|
Beta-Lactamases
& ESBLs
Karen
Bush (Johnson
& Johnson Pharmaceutical Research &
Development, USA) |
Metallo-Beta-Lactamase
& Carbapenemases
David
M. Livermore (Central
Public Health Laboratory, U.K.) |
Laboratory
Detection of ESBLs : Issues and Problems
Kyungwon
Lee (Yonsei
Univ., Korea) |
Clinical
Inplications of ESBLs
Hyunjoo
Pai (Hanyang
Univ.,Korea) |
Clinical Microbiology
Lab in the Era of Antibiotic Resistance
:
Current Issues and Future Trends |
|
|
Antimicrobial
Susceptibility Test : A Reappraisal
Eui-Chong
Kim (Seoul
National Univ., Korea) |
Genotypic
Susceptibility Testing : Principles and
Practices
Franklin
R. Cockerill (Mayo
Clinic, USA) |
Molecular
Typing of Antibiotic-Resistant Bacteria
Cheng-Hsun
Chiu (Chang
Gung Children's Hospital, Chinese Taipei)
|
DNA
Microarray for Detection of Resistance
Yeonhee
Lee (Seoul
Women’s Univ., Korea) |
|
|
|
Enterococcal
Resistance
In conjunction with Korean Society
of Infections Diseases |
|
|
The
Enterococci: a Continuing Therapeutic Challenge.
Barbara
E. Murray (Univ.
of Texas, USA) |
Mechanisms
of Glycopeptide and Oxazolidinone Resistance
in Enterococci
Wee
Gyo Lee (Ajou
Univ., Korea) |
Clinical
Implications of Glycopeptide-Resistant Enterococci
Walter
R. Wilson (Mayo
Clinic, USA) |
Current
Issues in the Management of Serious
Fungal Infections |
|
|
Antifungal
Resistance : How big is the problem?
Thomas
F. Patterson (Univ.
of Texas Health Science Center, USA) |
Treatment
of Systemic Candidal Infection
William
E. Dismukes (Univ.
of Alabama, USA) |
Treatment
of Invasive Aspergillosis
Thomas
F. Patterson (Univ.
of Texas Health Science Center, USA) |
Treatment
of Cryptococcal Disease
William
E. Dismukes (Univ.
of Alabama, USA) |
Antimicrobial
Resistance in the Hospital Setting
:
Problems and Strategies for Infection
Control
In conjunction with Philippine Society
for Microbiology and Infectious Diseases |
|
|
Growing
Problems of Antimicrobial Resistance among
Nosocomial Pathogens
Po-Ren
Hsueh (National
Taiwan Univ., Chinese Taipei) |
MRSA
: A Continuing Problem in the Hospital
Li
Jia Tai (Peking
Univ., P.R.China) |
Control
of Antimicrobial Resistance in the Hospital
: Infection Control Strategies
Wing
Hong Seto (Queen
Mary Hospital, P.R. China) |
Control
of Antimicrobial Resistance in the Hospital
:
Strategies for Antimicrobial Uses
Victor
Lim (Institute
of Medical Research, Malaysia) |
|
|
|
Glycopeptide-Resistant
S. Aureus & Community-Acquired
MRSA
In Conjunction with HongKong Society
for Infectious Diseases |
|
|
Community-Acquired
MRSA : is it a real threat?
Donald
J. Lyon (Prince
of Wales Hospital, P.R. China) |
Genomic
View of Virulence and Resistance in Community
Acquired MRSA
Keiichi
Hiramatsu (Juntendo
Univ., Japan) |
Vancomycin-Resistant
S. Aureus : Now & Future
Keiichi
Hiramatsu (Juntendo
Univ., Japan) |
Mechanism
of Glycopeptide Resistance
Longzhu
Cui (Juntendo
Univ., Japan) |
Current
Issues on HIV Treatment & Drug
Resistance |
|
|
Anti-Retroviral
Therapy in the Beginning of the 21st Century
Merle
Sande (Univ.
of Utah, USA) |
Monitoring
of Anti-Retroviral Resistance
Chris
Birch (Victorian
Infectious Diseases Reference Laboratory,
Australia) |
New
Therapeutic Agents against HIV/AIDS
Zelalem
Temesgen (Mayo
Clinic, USA) |
HIV
Vaccines in the Future
Young
Chul Sung (POSTECH,
Korea) |
Problems
in Antimicrobial Treatment in Children
:
Pediatric Perspectives on Resistance
In conjunction with Infectious Diseases
Association of Thailand /
Philippine Society for Microbiology
and Infectious Diseases /
Korean Society of Pediatric Infectious
Diseases |
|
|
Enteric
Infections
Nancy
Henry (Mayo
Clinic, USA) |
Current
Issues in Bacterial Meningitis Among Infants
and Children
Jung
Soo Kim (Chonbuk
National Univ., Korea) |
Are
interventions aiming at reduction of antibiotic
use effective against antibiotic resistance
in children?
Ron
Dagan (Soroka
Univ. Medical Center, Israel) |
Immunotherapy
of Neonatal Infections
Kwang
Sik Kim (Johns
Hopkins Univ., USA) |
|
|
|
Future
Stragegies for Antimicrobial Therapy
in the 21st Century |
|
|
Global
strategies against Antimicrobial Resistance
in the 21st Century : WHO Perspectives
Philip
G. Jenkins (World
Health Organization, Switzerland) |
Appropriate
Use of Antimicrobial Agents : PK/PD Approach
William
A. Craig (Univ.
of Wisconsin, USA) |
Clinical
Impact of Antimicrobial Resistance for the
Past Half Century
Walter
R. Wilson (Mayo
Clinic, USA) |
Governmental
Role for Control of Antimicrobial Resistance
Gun-Jo
Woo (Korea
Food & Drug Administration,Korea) |
|
|
|
New
Antimicrobial Agents
In Conjunction with Korean Society
for Chemotherapy |
|
|
Novel
Beta-Lactam Agents
Donald
E. Low (Mount
Sinai Hospital, Canada) |
Beta-Lactamase
inhibitors
Karen
Bush (Johnson
& Johnson Pharmaceutical Research &
Development, USA) |
Novel
Bridged Ketolide Antibiotic
Yat
Sun Or (Enanta
Pharmaceuticals, Inc.,USA) |
New
Drug Classes vs. Nosocomial Gram-Positive
Bacteria
David
M. Livermore (Central
Public Health Laboratory, U.K.) |
Genomics
and Proteomics for Development of
Novel Antibiotics |
|
|
Comprehensive
Approaches to Search for Novel Antibiotics
Sunghoon
Kim (Seoul National Univ.,
Korea) |
Protein
Structural Genomics for Drug Discovery
Thomas
Terwilliger (Los Alamos National
Laboratory, USA) |
Structural
Chemogenomics for the Discovery of Novel
Antibiotics
Seonggu
Ro (CrystalGenomics, Inc.,
Korea) |
Microbial
Genomics and Drug Discovery
Garry
Myers (The Institute for Genomic
Research, USA) |
Novel Vaccines
on the Horizon : New hopes against
resistance? |
|
|
Staphylococcal
Vaccines
Jean C.
Lee (Harvard
Medical School, USA) |
Pneumococcal
Vaccines
Keith
P. Klugman (Emory
Univ., USA) |
Future
Vaccines against Enteric Pathogens
John
Clemens (International
Vaccine Institute, USA) |
Pseudomonas
Vaccine : from Bench toBedside
Jang
Yun Lee (CJ
Corp., Korea) |
|
|
|
|
|
